BIA
RDY icon

Bell Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bell Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Sell
1,005
-719
-42% -$9.7K ﹤0.01% 580
2026
Q1 		$23.9K Sell
1,724
-119
-6% -$1.66K ﹤0.01% 406
2025
Q4 		$25.9K Buy
1,843
+863
+88% +$12.1K ﹤0.01% 374
2025
Q3 		$13.7K Buy
980
+55
+6% +$791 ﹤0.01% 530
2025
Q2 		$13.9K Buy
925
+640
+225% +$9.14K ﹤0.01% 551
2025
Q1 		$3.76K Sell
285
-362
-56% -$5K ﹤0.01% 1045
2024
Q4 		$10.2K Sell
647
-68
-10% -$1.02K ﹤0.01% 598
2024
Q3 		$11.4K Hold
715
– – ﹤0.01% 567
2024
Q2 		$10.9K Buy
715
+110
+18% +$1.58K ﹤0.01% 575
2024
Q1 		$8.88K Buy
605
+290
+92% +$4.23K ﹤0.01% 638
2023
Q4 		$4.38K Buy
315
+35
+13% +$468 ﹤0.01% 952
2023
Q3 		$3.75K Buy
280
+135
+93% +$1.83K ﹤0.01% 956
2023
Q2 		$1.83K Buy
145
+95
+190% +$1.11K ﹤0.01% 1345
2023
Q1 		$570 Sell
50
-50
-50% -$540 ﹤0.01% 1765
2022
Q4 		$1.03K Buy
+100
New +$1.08K ﹤0.01% 1572

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bell Investment Advisors's RDY Position: Q2 2026 in Review

Bell Investment Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 42% in Q2 2026, selling an estimated $9.7K and leaving 1,005 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Bell Investment Advisors first reported a position in RDY in Q4 2022 and has held it in 15 quarters since. The position peaked at $25.9K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Bell Investment Advisors held 1,005 shares of Dr. Reddy's Laboratories worth $14.6K as of Q2 2026.
  • Bell Investment Advisors sold 719 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $9.7K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #580 holding.
  • Bell Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Bell Investment Advisors's Dr. Reddy's Laboratories position peaked at $25.9K in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.